Artemis Medicare Services Limited Stock Price Today (NSE: ARTEMISMED)
Fundamental Score
Artemis Medicare Services Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Artemis Medicare Services Limited share price today is ₹327.95, up +3.31% on NSE/BSE as of 2 September 2026. Artemis Medicare Services Limited (ARTEMISMED) is a Small-cap company in the Hospital sector with a market capitalisation of ₹4.38K (Cr). The 52-week high for ARTEMISMED share price is ₹335.00 and the 52-week low is ₹203.35. At a P/E ratio of 38.51x, ARTEMISMED is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 11.69% and a debt-to-equity ratio of 0.24.
Artemis Medicare Services Limited Share Price Chart — NSE/BSE Historical Performance
Artemis Medicare Services Limited share price chart: 16.23% return over the past month. 52-week high ₹335.00, 52-week low ₹203.35.
Artemis Medicare Services Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹327.80 | ₹329.95 | ₹320.20 | ₹323.70 | 1.94L (Cr) | |
| ₹314.40 | ₹315.40 | ₹309.40 | ₹312.15 | 2.24L (Cr) | |
| ₹315.75 | ₹322.00 | ₹313.45 | ₹314.40 | 2.07L (Cr) | |
| ₹318.30 | ₹319.00 | ₹311.85 | ₹314.75 | 1.65L (Cr) | |
| ₹319.70 | ₹325.80 | ₹313.60 | ₹317.85 | 8.61L (Cr) | |
| ₹314.90 | ₹323.45 | ₹300.10 | ₹316.30 | 7.24L (Cr) | |
| ₹318.50 | ₹318.95 | ₹312.10 | ₹313.30 | 1.73L (Cr) | |
| ₹320.90 | ₹325.90 | ₹313.65 | ₹315.95 | 4.80L (Cr) | |
| ₹312.85 | ₹321.95 | ₹312.00 | ₹316.30 | 2.86L (Cr) | |
| ₹320.20 | ₹324.00 | ₹310.00 | ₹311.70 | 4.57L (Cr) |
Artemis Medicare Services Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹304.80 | ₹329.95 | ₹299.00 | ₹323.70 | +6.20% | |
| ₹263.65 | ₹308.00 | ₹258.40 | ₹298.50 | +13.22% | |
| ₹276.30 | ₹277.60 | ₹253.20 | ₹264.95 | -4.11% | |
| ₹244.13 | ₹295.00 | ₹243.01 | ₹273.36 | +11.97% | |
| ₹207.50 | ₹247.10 | ₹207.50 | ₹244.13 | +17.65% | |
| ₹234.12 | ₹237.35 | ₹203.35 | ₹205.51 | -12.22% | |
| ₹245.00 | ₹249.00 | ₹210.06 | ₹239.90 | -2.08% | |
| ₹271.95 | ₹280.60 | ₹221.00 | ₹247.95 | -8.83% | |
| ₹287.90 | ₹295.00 | ₹261.55 | ₹271.05 | -5.85% | |
| ₹247.56 | ₹297.50 | ₹240.35 | ₹285.46 | +15.31% | |
| ₹234.16 | ₹254.60 | ₹222.05 | ₹247.56 | +5.72% | |
| ₹219.10 | ₹251.77 | ₹219.10 | ₹234.18 | +6.88% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Small-cap hospital chain with aggressive expansion plans faces high promoter pledging and liquidity risk.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Artemis Medicare Services Ltd. experienced a volatile period. On March 30, 2026, the stock fell to a 52-week low of However, it rebounded strongly on April 1, 2026, with a 7.87% surge, closing at The week closed on April 3, 2026, at , a 3.25% gain for the week, outperforming the Sensex. The trading window closed on April 1, 2026, in anticipation of Q4 results.
CORE STORY (THE REAL GAME)
Artemis is a small-cap hospital chain attempting aggressive expansion while managing promoter pledging risk. The market is trying to figure out if they can scale without imploding.
- Raipur facility commissioning in April 2026
- Q3 FY26 showed strong profitability surge
- Technical rebound from 52-week low
- Successful commissioning and ramp-up of Raipur hospital
- Significant order wins or contracts
- Reduction in promoter pledging
- High promoter pledging (44.53%)
- Small-cap liquidity risk
- Expansion execution risk
FII increased stake significantly (Δ 12.24%), while DII decreased (Δ -1.41%), indicating mixed institutional sentiment.
Potential increase in hospital bills and medicine costs due to geopolitical tensions (Iran War).
Raipur facility commissioning scheduled for April 2026.
Free Cash Flow 5Y: ₹33.75 Cr, indicating limited cash generation.
Next 3-6 months hinge on successful Raipur facility launch and Q4 results. Monitor promoter pledging and liquidity closely.
Primary Thesis Risk
Promoter pledging could trigger a collapse if the stock falters.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Artemis Medicare Services Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Artemis Medicare Services Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ARTEMISMED across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Attractive Valuation (P/E: 38.51 vs Industry: 48.79)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (47.14%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (21.50% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (75.86% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.24)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (6.03x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 1.74)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (58.43%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
0 factors identified
No significant concerns identified in current analysis.
Artemis Medicare Services Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Artemis Medicare Services Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Artemis Medicare Services LimitedArtemis Medicar...Selected✓ ARTEMISMED • 542919 | 69.5/100 | ₹327.95₹328 | ₹4376.46₹4376.46 | 38.51Average 38.5 Average | 11.69%Average 11.69% Average | 14.15%Average 14.15% Average | 0.24Excellent 0.2 Excellent | 75.86%Excellent 75.86% Excellent | 21.50%Excellent 21.50% Excellent | 0.16% |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8889.00₹8889 | ₹128448.55₹128448.55 | 61.47Average 61.5 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1016.00₹1016 | ₹107422.79₹107422.79 | 73.71Average 73.7 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | — — | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹923.95₹924 | ₹73687.64₹73687.64 | 70.32Average 70.3 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | — — | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 37.2/100 | ₹765.25₹765 | ₹71917.90₹71917.90 | 225.67Average 225.7 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 68.3/100 | ₹1890.10₹1890 | ₹41592.95₹41592.95 | 50.96Average 51.0 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | — — | 25.05%Excellent 25.05% Excellent | 0.22% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 59.9/100 | ₹1404.40₹1404 | ₹35993.93₹35993.93 | 64.72Average 64.7 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.04% |
13.9/100 | ₹772.50₹773 | ₹33947.05₹33947.05 | 166.00Average 166.0 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 48.5/100 | ₹500.40₹500 | ₹15618.15₹15618.15 | 105.26Average 105.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | — — | — — | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 65.5/100 | ₹1445.20₹1445 | ₹15270.28₹15270.28 | 53.51Average 53.5 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | — — | — — | 0.23% |
60/100 | ₹298.70₹299 | ₹9829.95₹9829.95 | 52.28Average 52.3 Average | 13.41%Average 13.41% Average | 15.25%Good 15.25% Good | 0.33Excellent 0.3 Excellent | — — | — — | 0.07% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price128448.55 Cr
- Max Healthcare Institute Limited share price107422.79 Cr
- Fortis Healthcare Limited share price73687.64 Cr
- Aster DM Quality Care Limited share price71917.90 Cr
- Narayana Hrudayalaya Ltd. share price41592.95 Cr
Artemis Medicare Services Limited Quarterly Performance
Latest quarterly metrics for ARTEMISMED — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
12.69%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
47.14%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
21.50%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
75.86%
Compounded annual net profit growth over 5 years
Artemis Medicare Services Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ARTEMISMED — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Artemis Medicare Services Limited Financial Statements
Annual income statement, balance sheet and cash flow for Artemis Medicare Services Limited (ARTEMISMED) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Artemis Medicare Services Limited
About ARTEMISMED (Artemis Medicare Services Limited)
Artemis Medicare Services Ltd is a prominent healthcare provider, weaving a tapestry of medical expertise across its network of hospitals. Each facility is a hub of advanced techno...logy and compassionate care, designed to cater to a diverse range of medical needs. From intricate surgical procedures to comprehensive medical management, Artemis hospitals are equipped with state-of-the-art diagnostic tools and treatment modalities. They foster an environment of healing, where patient well-being is at the heart of every endeavor. Artemis remains committed to fostering excellence and setting new standards in the delivery of healthcare services. Beyond the core medical and surgical interventions, Artemis Medicare Services Ltd emphasizes holistic patient care, recognizing the interconnectedness of physical and emotional well-being. Patients and their families benefit from a comprehensive suite of support services. This includes specialized programs like emotional support and counseling, nutritional guidance, and even childcare facilities, easing the burden on families during challenging times. Multilingual medical interpreters facilitate effective communication for international patients, ensuring a seamless and comfortable experience. Artemis proactively promotes a patient-centric approach by actively involving patients and their families in the decision-making process through advisory councils. The Artemis Medicare Services Ltd commitment to excellence is further demonstrated through cutting-edge initiatives like telemedicine and patient portals. These innovations improve accessibility to healthcare. Patients can effortlessly schedule appointments, access their medical records, and communicate with healthcare professionals remotely. The focus on continuous innovation allows Artemis to extend its reach and cater to a growing number of patients across India and internationally. Artemis Medicare strives to provide accessible, affordable, and high-quality healthcare to all.
Company Details
Key Leadership
Corporate Events
ARTEMISMED Share Price: Frequently Asked Questions
What is the current share price of Artemis Medicare Services Limited?
Artemis Medicare Services Limited (ARTEMISMED) trades at ₹327.95 on NSE and BSE. Market cap ₹4.38K (Cr). Educational data only.
What is the P/E ratio of Artemis Medicare Services Limited?
Artemis Medicare Services Limited has a P/E of 38.51x vs industry average 48.79x.
What is the Bull Run score for Artemis Medicare Services Limited?
Artemis Medicare Services Limited has a Bull Run score of 69.5/100 based on 25+ financial parameters.
Does Artemis Medicare Services Limited pay dividends?
Artemis Medicare Services Limited has a dividend yield of 0.16%. Past dividends don't guarantee future payments.
What is the ROE of Artemis Medicare Services Limited?
Artemis Medicare Services Limited has ROE of 11.69%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Artemis Medicare Services Limited?
Artemis Medicare Services Limited has debt-to-equity of 0.24.
Is Artemis Medicare Services Limited a good investment?
Bull Run gives Artemis Medicare Services Limited a score of 69.5/100. This is not investment advice — consult a SEBI-registered advisor.